ESEric W. Stawiski

Eric W. Stawiski

*This is an algorithmically generated author record based on publicly available information.

Eric W. Stawiski has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comprehensive genomic analysis identifies pathogenic variants in maturity-onset diabetes of the young (MODY) patients in South India

    by Viswanathan Mohan, Venkatesan Radha, Thong T. Nguyen, Eric W. Stawiski, Kanika Bajaj Pahuja, Leonard D. Goldstein, Jennifer Tom, Ranjit Mohan Anjana, Monica Kong-Beltran, Tushar Bhangale, et al.

    Maturity-onset diabetes of the young (MODY) is an early-onset, autosomal dominant form of non-insulin dependent diabetes. Genetic diagnosis of MODY can transform patient management. Earlier data on the genetic predisposition to MODY have come primarily from familial studies in populations of European origin. In this study, we carried out a comprehensive genomic analysis of 289 individuals from India that included 152 clinically diagnosed MODY cases to identify variants in known MODY genes. Further, we have analyzed exome data to identify putative MODY relevant variants in genes previously not implicated in MODY. Functional validation of MODY relevant variants was also performed. We found MODY 3 (HNF1A; 7.2%) to be most frequently mutated followed by MODY 12 (ABCC8; 3.3%). They together account for ~ 11% of the cases. In addition to known MODY genes, we report the identification of variants in RFX6, WFS1, AKT2, NKX6–1 that may contribute to development of MODY. Functional assessment of the NKX6–1 variants showed that they are functionally impaired. Our findings showed HNF1A and ABCC8 to be the most frequently mutated MODY genes in south India. Further we provide evidence for additional MODY relevant genes, such as NKX6–1, and these require further validation.


  • Open Access

    Genomic variant calling: Flexible tools and a diagnostic data set

    by Michael Lawrence, Melanie A. Huntley, Eric Stawiski, Art Owen, Thomas D Wu, Leonard D Goldstein, Yi Cao, Jeremiah Degenhardt, Jason Young, Joseph Guillory, et al.

    1 The accurate identification of low-frequency variants in tumors remains an unsolved problem. To support characterization of the issues in a realistic setting, we have developed software tools and a reference dataset for diagnosing variant calling pipelines. The dataset contains millions of variants at frequencies ranging from 0.05 to 1.0. To generate the dataset, we performed whole-genome sequencing of a mixture of two Corriel cell lines, NA19240 and NA12878, the mothers of YRI (Y) and CEU (C) HapMap trios, respectively. The cells were mixed in three different proportions, 10Y/90C, 50Y/50C and 90Y/10C, in an effort to simulate the heterogeneity found in tumor samples. We sequenced three biological replicates for each mixture, yielding approximately 1.4 billion reads per mixture for an average of 64X coverage. Using the published genotypes as our reference, we evaluate the performance of a general variant calling algorithm, constructed as a demonstration of our flexible toolset, and make comparisons to a standard GATK pipeline. We estimate the overall FDR to be 0.028 and the FNR (when coverage exceeds 20X) to be 0.019 in the 50Y/50C mixture. Interestingly, even with these relatively well studied individuals, we predict over 475,000 new variants, validating in well-behaved coding regions at a rate of 0.97, that were not included in the published genotypes.

  • Open Access

    Diverse modes of genomic alteration in hepatocellular carcinoma

    by Suchit Jhunjhunwala, Zhaoshi Jiang, Eric W Stawiski, Florian Gnad, Jinfeng Liu, Oleg Mayba, Pan Du, Jingyu Diao, Stephanie Johnson, Kwong-Fai Wong, et al.

    Background: Hepatocellular carcinoma (HCC) is a heterogeneous disease with high mortality rate. Recent genomic studies have identified TP53, AXIN1, and CTNNB1 as the most frequently mutated genes. Lower frequency mutations have been reported in ARID1A, ARID2 and JAK1. In addition, hepatitis B virus (HBV) integrations into the human genome have been associated with HCC. Results: Here, we deep-sequence 42 HCC patients with a combination of whole genome, exome and transcriptome sequencing to identify the mutational landscape of HCC using a reasonably large discovery cohort. We find frequent mutations in TP53, CTNNB1 and AXIN1, and rare but likely functional mutations in BAP1 and IDH1. Besides frequent hepatitis B virus integrations at TERT, we identify translocations at the boundaries of TERT. A novel deletion is identified in CTNNB1 in a region that is heavily mutated in multiple cancers. We also find multiple high-allelic frequency mutations in the extracellular matrix protein LAMA2. Lower expression levels of LAMA2 correlate with a proliferative signature, and predict poor survival and higher chance of cancer recurrence in HCC patients, suggesting an important role of the extracellular matrix and cell adhesion in tumor progression of a subgroup of HCC patients. Conclusions: The heterogeneous disease of HCC features diverse modes of genomic alteration. In addition to common point mutations, structural variations and methylation changes, there are several virus-associated changes, including gene disruption or activation, formation of chimeric viral-human transcripts, and DNA copy number changes. Such a multitude of genomic events likely contributes to the heterogeneous nature of HCC.